Assenagon Asset Management S.A. Emergent Bio Solutions Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 741,552 shares of EBS stock, worth $6.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

741,552

Previous 424,852 74.54%

Holding current value

$6.04 Million

Previous $2.9 Million 113.7%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$5.72 - $14.77 $1.81 Million - $4.68 Million	316,700 Added 74.54%	741,552 $6.19 Million
Q2 2024 Jul 18, 2024	SELL	$1.86 - $6.98 $771,085 - $2.89 Million	-414,562 Reduced 49.39%	424,852 $2.9 Million
Q1 2024 Apr 24, 2024	BUY	$1.5 - $3.41 $7,563 - $17,193	5,042 Added 0.6%	839,414 $2.12 Million
Q4 2023 Jan 17, 2024	BUY	$1.82 - $3.16 $1.19 Million - $2.06 Million	651,480 Added 356.21%	834,372 $2 Million
Q3 2023 Nov 06, 2023	BUY	$3.17 - $7.91 $277,863 - $693,343	87,654 Added 92.04%	182,892 $621,000
Q2 2023 Jul 25, 2023	BUY	$7.35 - $13.21 $699,999 - $1.26 Million	95,238 New	95,238 $699,000
Q4 2022 Jan 12, 2023	BUY	$11.0 - $21.45 $161,095 - $314,135	14,645 Added 33.01%	59,007 $697,000
Q3 2022 Oct 27, 2022	SELL	$20.09 - $35.8 $1.91 Million - $3.4 Million	-94,954 Reduced 68.16%	44,362 $931,000
Q2 2022 Jul 27, 2022	BUY	$27.42 - $43.63 $2.2 Million - $3.5 Million	80,223 Added 135.76%	139,316 $4.32 Million
Q1 2022 Apr 25, 2022	SELL	$36.48 - $52.22 $3.37 Million - $4.82 Million	-92,330 Reduced 60.97%	59,093 $2.43 Million
Q4 2021 Feb 01, 2022	BUY	$33.11 - $55.01 $3.85 Million - $6.4 Million	116,297 Added 331.09%	151,423 $6.58 Million
Q3 2021 Oct 19, 2021	BUY	$50.07 - $66.05 $442,218 - $583,353	8,832 Added 33.59%	35,126 $1.76 Million
Q2 2021 Jul 15, 2021	BUY	$56.61 - $80.46 $1.49 Million - $2.12 Million	26,294 New	26,294 $1.66 Million
Q4 2020 Feb 01, 2021	SELL	$79.17 - $111.47 $1.55 Million - $2.18 Million	-19,600 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$81.91 - $134.94 $1.61 Million - $2.64 Million	19,600 New	19,600 $2.03 Million
Q4 2019 Jan 17, 2020	SELL	$51.21 - $59.06 $809,630 - $933,738	-15,810 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$40.6 - $57.2 $641,886 - $904,332	15,810 New	15,810 $827,000
Q1 2019 Apr 26, 2019	SELL	$48.23 - $66.16 $1.18 Million - $1.62 Million	-24,443 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$55.63 - $73.24 $1.36 Million - $1.79 Million	24,443 New	24,443 $1.45 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $406M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Emergent Bio Solutions Inc. Transaction History